PainChek rises on getting regulatory approvals in UK, Australia

PainChek

17/03/2021 01:25

** Shares of pain assessment app developer PainChek Ltd
 PCK.AX  gain as much as 15.9% to A$0.08- their biggest intraday
percentage gain since Feb 18
    ** Co says its 'Universal Pain Assessment Solution' got CE
Mark clearance in Europe and the United Kingdom  urn:newsml:reuters.com:*:nFWN2LE0Q9
    ** PCK says it also received Therapeutic Goods
Administration (TGA), a regulatory body, clearance in Australia
    ** Co says its initial rollout of the Universal application
is commencing in April 2021 in Australia and United Kingdom
before expanding to other markets including mainland Europe
    ** Stock hits its highest level since March 4
    ** About 6.7 mln shares change hands compared to the 30-day
average volume of 2.1 mln shares
    ** PCK had fallen 10.4% this year, as of last close
       

 (Reporting by Aditya Munjuluru in Bengaluru)
 ((aditya.srivastsav@thomsonreuters.com))